Risks and Benefits of Obinutuzumab-Based Chemotherapy in the Context of SARS-CoV-2 Infection.

Publication date: Jul 10, 2025

Concepts Keywords
Benefits bendamustine
Chemotherapy coronavirus disease 2019 (COVID-19)
Infection follicular lymphoma
Intern obinutuzumab
Obinutuzumab

Semantics

Type Source Name
drug DRUGBANK Obinutuzumab
disease MESH SARS-CoV-2 Infection
pathway REACTOME SARS-CoV-2 Infection
drug DRUGBANK Bendamustine
disease MESH follicular lymphoma

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *